A059210 Stock Overview
Engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Meta Biomed Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,545.00 |
| 52 Week High | ₩5,570.00 |
| 52 Week Low | ₩3,210.00 |
| Beta | 0.70 |
| 1 Month Change | 0% |
| 3 Month Change | -12.58% |
| 1 Year Change | -17.27% |
| 3 Year Change | 32.03% |
| 5 Year Change | 28.91% |
| Change since IPO | -33.43% |
Recent News & Updates
Recent updates
Meta Biomed (KOSDAQ:059210) Shareholders Will Want The ROCE Trajectory To Continue
Dec 17
Earnings Tell The Story For Meta Biomed Co., Ltd. (KOSDAQ:059210) As Its Stock Soars 30%
Feb 26Here's How We Evaluate Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Dividend
Apr 11Meta Biomed's (KOSDAQ:059210) Stock Price Has Reduced 58% In The Past Five Years
Mar 14Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 21Can Meta Biomed (KOSDAQ:059210) Continue To Grow Its Returns On Capital?
Feb 03
Is Meta Biomed (KOSDAQ:059210) A Risky Investment?
Jan 13Here's Why I Think Meta Biomed (KOSDAQ:059210) Is An Interesting Stock
Dec 26Meta Biomed (KOSDAQ:059210) Share Prices Have Dropped 22% In The Last Five Years
Dec 08Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 20Shareholder Returns
| A059210 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -2.9% | -3.2% | -3.7% |
| 1Y | -17.3% | -3.0% | -10.4% |
Return vs Industry: A059210 underperformed the KR Medical Equipment industry which returned -3.1% over the past year.
Return vs Market: A059210 underperformed the KR Market which returned -10.4% over the past year.
Price Volatility
| A059210 volatility | |
|---|---|
| A059210 Average Weekly Movement | 5.2% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A059210 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A059210's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 271 | Suk-Song Oh | www.meta-biomed.com |
Meta Biomed Co., Ltd. engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa. The company's dental products include endodontics, dental equipment, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products; suture materials, such as functional and orthopedic suture materials; biomaterials, that includes polymer, multifilament yarn, 3D printing filaments, and bioceramic powder; and auxiliary materials, such as aluminum pouch, needle and glue, glove box, barbing machine, and diameter tester, as well as functional filaments.
Meta Biomed Co., Ltd. Fundamentals Summary
| A059210 fundamental statistics | |
|---|---|
| Market cap | ₩81.08b |
| Earnings (TTM) | ₩15.19b |
| Revenue (TTM) | ₩92.30b |
5.3x
P/E Ratio0.9x
P/S RatioIs A059210 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A059210 income statement (TTM) | |
|---|---|
| Revenue | ₩92.30b |
| Cost of Revenue | ₩49.79b |
| Gross Profit | ₩42.51b |
| Other Expenses | ₩27.32b |
| Earnings | ₩15.19b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 664.31 |
| Gross Margin | 46.06% |
| Net Profit Margin | 16.46% |
| Debt/Equity Ratio | 66.2% |
How did A059210 perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield3%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 16:54 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Meta Biomed Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|